CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kolmar BioTech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kolmar BioTech Inc
Kolmar Biocluster
593-8, Dongtangiheung-ro, Dongtan-gu
Phone: +82 318889341p:+82 318889341 HWASEONG, 18469  South Korea Ticker: 215380215380

Business Summary
Kolmar BioTech Inc, formerly Woojung Bio Inc, is a Korea-based company principally engaged in the provision of biotechnology research and development services. The Company operates its business through three segments. The engineering and construction (E&C) segment is engaged in the design, construction, modernization and maintenance of good manufacturing practice (GMP) facilities, cleanrooms, laboratories and laboratory animal facilities. The segment is also engaged in the manufacture and sale of laboratory equipment and pharmaceutical equipment such as research and analytical equipment, isolators, space sterilizers as well as others. The Bio segment is engaged in the non-clinical contract research organization (CRO) services. The Lab Cloud Rental segment is engaged in the operation and leasing of shared laboratory infrastructure for biotechnology ventures, startups and research institutions.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202612/31/2025Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Hui JeongCheon 36 5/21/2025 3/28/2025
Internal Auditor Sang CheolAhn 49
Internal Auditor GeonOh 59 3/7/2017 3/7/2017
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 122 (As of 3/31/2026)
Outstanding Shares: 16,670,536 (As of 3/31/2026)
Shareholders: 11,170
Stock Exchange: KDQ
Fax Number: +82 3180566561


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 26, 2026